Will DXCM Q2 Earnings Reflect U.S. Coverage Expansion & Stelo Impact?

Key Takeaways DXCM Q2 revenues are expected to be $1.12B, up 11.8%, with EPS forecast to rise 4.7% to $0.45.Expanded U.S. CGM access and Stelos Amazon launch likely boosted adoption and patient starts.G7 ramp and international growth may aid margins, though DXCM holds 0.00% ESP ahead of earnings. DexCom, Inc. (DXCM) is scheduled to release second-quarter 2025 results on July 30, after the closing bell. In the last reported quarter, the company’s earnings missed estimates by 3.03%.The bottom line outpaced th ...